1, with a group of relatively mature business operators.

2. The performance needs to be completed accurately. If it is not completed, the shares should be recovered and cancelled according to the gambling agreement. Potentially positive, if the restructuring performance is gambling, the stock price will double.

3. For this bet, tongjitang's annual performance was accurately completed. Only a little more every year. But now under review, it may be performance fraud. If it is performance fraud. 90% of gambling shows can't be completed. If it can't be completed, it will lead to gambling conditions. According to the agreement, many shares must be withdrawn and cancelled. Share prices will double. Expect.

First, tongjitang medicine

1. Since last August, tongjitang Pharmaceutical Co., Ltd. has been caught in a negative whirlpool, such as the bank loans overdue, the financial report being issued with an audit report that cannot express opinions, the parent company being investigated by the CSRC, and the related parties occupying a large amount of funds. Since then, its credit rating has been lowered.

2. Default

On April 27th, tongjitang (600090. SH) It was announced that the liquidity of tongjitang Pharmaceutical Co., Ltd. (hereinafter referred to as "tongjitang Pharmaceutical"), a wholly-owned subsidiary, was tense in stages, and it was temporarily unable to pay bonds on schedule, which had a great impact on the company's refinancing. Up to now, "18 Tongji 0 1" has not paid the principal and interest of 230 million yuan; "18 Tongji 02" has not paid the principal and interest of 229.9 million yuan. According to the public information of overdue bond announcement, "18 Tongji 0 1" and "18 Tongji 02" were issued in April 20 18, and the principal of 420 million yuan should be paid on April 25 this year. Tongjitang provides unconditional and irrevocable joint liability guarantee for bonds, and the guarantee period is two years after the bond's duration and maturity.

3. According to the announcement, in order to resolve the debt risk, tongjitang and tongjitang Pharmaceuticals actively adjusted their operations and conducted multi-party financing. The controlling shareholders also stepped up the disposal of assets and accelerated the recovery of funds of tongjitang Pharmaceuticals.

4. Up to now, tongjitang Pharmaceutical and its creditors have made on-site confirmation and preliminary communication on the disposal of assets by the controlling shareholders, and negotiated the deferred payment scheme of bonds.

5. On April 23rd, China Chengxin International downgraded the credit rating of tongjitang Pharmaceutical from B to CC, and downgraded the credit ratings of "18 Tongji 0/"and "18 Tongji 02" from B to CC; And the subject and credit rating of the above debts will continue to be included in the watch list that may be downgraded. Meanwhile, China Chengxin International downgraded tongjitang's main credit rating from B to CC, and kept tongjitang's main credit rating on the watch list for possible downgrade.

Second, the debt crisis broke out

1, tongjitang (600090. SH) is a large enterprise group, mainly engaged in drugs and devices, mainly targeting medical institutions, wholesale enterprises and retail pharmacies, providing customers with various value-added services such as information and logistics. 20 15 was listed on the backdoor of hops.

2. official website shows that tongjitang Pharmaceutical Co., Ltd. was established in 2000. It is a modern large-scale pharmaceutical logistics retail chain enterprise established by introducing foreign advanced pharmaceutical retail chain management mode and combining with domestic reality.